|
Market Closed -
Nasdaq
00:00:00 02/04/2025 +04
|
5-day change | 1st Jan Change | ||
| 131.87 USD | -0.04% |
|
-.--% | - |
| 15/04/25 | J&J Boosts Outlook Despite Incoming Tariff Costs -- Update | DJ |
| 15/04/25 | J&J Increases Outlook After Beating 1Q Expectations | DJ |
Stock exchange
Nasdaq
ITCI 131.87 $
-0.04%
2.12B
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | -0.04% | ||
| 3 years | +133.85% | ||
| 5 years | +302.41% | ||
| 10 years | +203.43% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
14,021,467,030
Net sales ()
680,852,000
Number of employees
860
Sales / Employee (USD)
791,688
Free-Float
95.68%
Free-Float capitalization (USD)
13,440,685,967
Indicators
Moving average 5 days
131.84
Moving average 100 days
109.74
Price spread / (MMA5)
-0.02%
Price spread / (MMA100)
-16.78%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | -.--% | -.--% | +133.85% | 14.02B | |
| -2.47% | -4.47% | +35.19% | -5.99% | 79.26B | |
| -1.99% | +2.45% | +502.05% | +25.46% | 58.56B | |
| +1.57% | +0.62% | -16.15% | -34.72% | 58.62B | |
| -0.56% | -3.68% | -11.53% | +25.63% | 48.75B | |
| -0.29% | -0.19% | +1.21% | +154.61% | 46.32B | |
| -0.55% | +1.73% | +50.83% | -15.16% | 32.12B | |
| -0.37% | -2.14% | +46.43% | +94.63% | 24.77B | |
| -1.91% | -6.22% | -2.91% | +151.66% | 21.5B | |
| -1.92% | -2.31% | +62.94% | +96.25% | 15.97B | |
| Average | -0.87% | -1.69% | +66.81% | +62.62% | 39.99B | |
| Weighted average by Cap. | -0.92% | -1.76% | +86.19% | +39.82% |
Historical Quotes: Intra-Cellular Therapies, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 45.5 |  | 131.98 |
| 5 years | 33.15 | | 131.98 |
| 10 years | 6.75 | | 131.98 |
Monthly variations
Annual variations
| 2025 | +57.89% | ||
| 2024 | +16.62% | ||
| 2023 | +35.34% | ||
| 2022 | +1.11% | ||
| 2021 | +64.59% | ||
| 2020 | -7.32% | ||
| 2019 | +201.23% | ||
| 2018 | -21.34% | ||
| 2017 | -4.04% | ||
| 2016 | -71.95% | ||
| 2015 | +204.76% | ||
| 2014 | -11.75% | ||
| 2013 | +100.00% |
- Stock Market
- Stocks
- ITCI Stock
- Quotes Intra-Cellular Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
